Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Alm. Brand – Report on trading in Alm. Brand A/S shares by executives and their related parties
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TT ELECTRONICS PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BRITVIC PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AVIVA PLC - Ordinary Shares
-
Phil Murphy Joins Synergy ECP as President and COO
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
DIRECTOR / PDMR NOTIFICATION
-
Issue of Equity and Total Voting Rights
-
In an Open Letter to VEON Investors, VEON Group CEO Welcomes the Unfreezing of VEON’s Corporate Rights on Kyivstar
-
EnerVenue Provides RWE with Long-Duration Energy Storage Vessels™ for Pilot Project
-
In an Open Letter to VEON Investors, VEON Group CEO Welcomes the Unfreezing of VEON’s Corporate Rights on Kyivstar
-
AlveoGene’s Novel, Inhaled Gene Therapy AVG-002 Receives Orphan Drug Designation from FDA for Lethal Neonatal Surfactant Protein B (SP-B) Deficiency
-
Global Ascension Studios Embarks on a Bold Journey with Groundbreaking Industry Partnerships Across Film, TV, and News
-
New Hydrogen CEO Steve Hill and University of Massachusetts Expert Discuss Intersection Between Hydrogen and Wind Energy
-
Kitron: Kitron to host Capital Markets Presentation
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Form 8.5 (EPT/RI) - NewRiver REIT Plc
-
RCI Banque discloses Capital Requirements following the 2024 SREP draft decision.
-
One Ambulance Can Save Lives: Okean Elzy and Open Eyes Aim to Reach Goal of 30 Vehicles at London Concert
-
Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chief Business Officer
-
Pacific Green expands Australia footprint into New South Wales with strategic land acquisition
-
Sampo's Christmas donation to the Red Cross
-
Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chief Business Officer
-
Tivoli increase expectations following a historic Halloween and solid to the Christmas season
-
Share buybacks in Spar Nord Bank – transactions in week 48
-
IDEX Biometrics ASA: Mandatory notification of trade by primary insiders – 3 Dec 2024
-
Warrants of series TO8 were exercised to approximately 88 percent and Terranet will receive approximately SEK 17.2 million
-
Nasdaq Study Shows Firms Turning to AI and Data Scientists to Enhance Regulatory Compliance
-
Agreement reached between Atos and Unisys regarding the lawsuit filed by Unisys against Atos and two Atos employees
-
Virbac: Türkiye: Virbac acquires its companion animal distributor
-
STX Group Expands Its Biofuels Business With Strategic Acquisition of Marine Olie
-
21X secures historic EU license to launch the first fully regulated blockchain-based trading venue
-
Greenlight Insurance Launches New Relationship with MoneySuperMarket
-
WOO X Welcomes Caladan as Lead Trader, Empowering Retail Investors with Institutional-Grade Strategies
-
AAVantgarde announces oral presentation of LUCE-1 clinical study at FLORetina 2024 annual meeting
-
Equinor ASA: Share buy-back
-
MARTIN FISCHER TO SUCCEED PATRICK KOLLER AS CEO OF FORVIA, EFFECTIVE MARCH 1, 2025
-
Progress on share buyback programme
-
Avaloq and Quadient Partner to Elevate Client Communications for Financial Services
-
International Petroleum Corporation Announces TSX Approval for Renewal of Normal Course Issuer Bid
-
Transaction in Own Shares
-
Vow ASA: Last day of trading in subscription rights
-
AS Tallink Grupp Statistics for November 2024
-
UBS O'Connor Invests £50 Million in VC VentureX to Accelerate Digital Asset Strategy
-
Ampere and STMicroelectronics collaborate on powerbox with long term supply for silicon carbide
-
Invalda INVL investor’s calendar for 2025
-
Bureau Veritas strengthens its positioning in luxury and fashion through the acquisition of LBS Group
-
Immunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma
-
Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®


